SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
186
SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Qualcomm Incorporated of Class Action Lawsuit and Upcoming Deadline – QCOM

NEW YORK, Aug. 04, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Qualcomm Incorporated (“Qualcomm” or the “Company”) (NASDAQ:  QCOM) and certain of its officers.  The class action, filed in United States District Court, Southern District of California, and docketed under index 18-cv-01457, is on behalf of a class consisting of investors who purchased or otherwise acquired Qualcomm securities, between January 31, 2018 and March 12, 2018, inclusive (the “Class Period”), seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”) against QUALCOMM and certain of its senior officers (collectively, “Defendants”).

If you are a shareholder who purchased Qualcomm securities between January 31, 2018, and March 12, 2018, both dates inclusive, you have until August 7, 2018, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com .  To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased. 

[Click here to join this class action]

QUALCOMM develops and commercializes “foundational technologies and products used in mobile devices and other wireless products.” According to the Company’s Annual Report on Form 10-K, filed with the SEC on November 1, 2017, QUALCOMM is “a pioneer in 3G (third generation) and 4G (fourth generation) wireless technologies, and [is] a leader in 5G (fifth generation) wireless technologies to empower a new era of intelligent, connected devices.” The Company derives revenues principally from the sale of integrated circuit products and the licensing of intellectual property.

Broadcom Limited (“Broadcom”) is a designer, developer and global supplier of a broad range of semiconductor devices, with a focus on complex digital and mixed signal complementary metal oxide semiconductor (“CMOS”) based devices and analog III-V based products. Broadcom is incorporated, and maintains its principal executive offices, in Singapore. Beginning in November 2017, Broadcom announced a series of unsolicited proposals to acquire all of the outstanding shares of QUALCOMM’s common stock.

Unbeknownst and undisclosed to investors, on January 29, 2018, QUALCOMM secretly filed a voluntary request for the Committee on Foreign Investment in the United States (“CFIUS”) to initiate an investigation into Broadcom’s actions in an effort to frustrate Broadcom’s attempt to acquire the Company. Once the Company’s undisclosed unilateral action was revealed to the market on March 5, 2018, and as the market continued to learn additional information about the nature and extent of QUALCOMM’s secret action vis-à-vis CFIUS, and the ramifications therefrom, the price of the Company’s common stock declined substantially.

On March 5, 2018, Broadcom issued a press release entitled “Broadcom Disappointed Will of Qualcomm Stockholders to be Deferred.” That press release disclosed QUALCOMM’s secret actions with respect to CFIUS as follows, stating that “Qualcomm secretly filed a voluntary request with CFIUS to initiate an investigation, resulting in a delay of Qualcomm’s Annual Meeting 48 hours before it was to take place.”  The Broadcom press release characterized Qualcomm’s actions as “a blatant, desperate act by Qualcomm to entrench its incumbent board of directors and prevent its own stockholders from voting for Broadcom’s independent director nominees.”

Also on March 5, 2018, QUALCOMM filed a Current Report on Form 8-K with the SEC disclosing that it had “received an Interim Order” from CFIUS (the “March 4, 2018 Interim Order”). A copy of the March 4, 2018 Interim Order was attached to the Form 8-K as Exhibit No. 99.1. Among other things, the March 4, 2018 Interim Order directed that “[Q]ualcomm’s annual stockholder meeting, including the election of its Board of Directors, shall be delayed from its current scheduled date of March 6, 2018, for a period of 30 (thirty) days. Qualcomm shall hold in abeyance the acceptance or count of any votes or proxies for directors, and shall take no action to complete the election of directors.”

Following this news, the price of the Company’s common stock declined $0.73 per share, or 1.13%, to close at $64.01 per share on March 5, 2018

On March 6, 2018, QUALCOMM filed a Current Report on Form 8-K with the SEC disclosing that it had (i) “received a letter, addressed to both Broadcom Limited and Qualcomm, from the U.S. Department of Treasury” (the “March 5, 2018 Letter”); and (ii) “received a Modification of Interim Order” from CFIUS (the “Modification of Interim Order”). Copies of the March 5, 2018 Letter and the Modification of Interim Order were attached to the Current Report on Form 8-K as Exhibits.  The March 5, 2018 Letter shed further light on QUALCOMM’s actions, and the resulting impact of such actions, stating that “the U.S. Department of Treasury (“Treasury”) filed an agency notice pursuant to 31 C.F.R. §800.401(c) broadening the scope of review [of its inquiry] to cover the proposed hostile takeover of Qualcomm.”

Following this news, the price of the Company’s common stock declined an additional $1.87 per share, or 2.92%, to close at $62.14 per share on March 6, 2018.

On March 12, 2018, post-market, President Donald J. Trump issued an order blocking Broadcom from taking further action regarding its proposed acquisition of QUALCOMM.

Following this development, the price of the Company’s common stock declined an additional $3.11 per share, or 4.95%, to close at $59.70 per share on March 13, 2018.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 108

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 39

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
ACOLT Bets on Gold, Craft, and a Sci-Fi Story World

Updated Category News Views 43

A gold pendant moonlighting as a plot device is not the usual luxury pitch, and thank goodness for that. ACOLT, the Denver-based men's fine jewelry house founded by Colton Hindle, plans an international December 2026 launch of its Gold Collection alongside CHRYSON Volume 1: The Arrival, an original science-fiction comic. The actual hand-forged pieces are meant to show up...

Continue Reading
Schloss Johannisberg Leads 2026 Global Vineyard List

Updated Category News Views 179

A 1,200-year-old riesling estate just beat the world at being memorable. Schloss Johannisberg in Germany’s Rheingau has taken No. 1 in The 50 Best Vineyards 2026, moving up from No. 2 last year and also claiming Best Vineyard in Europe. For anyone watching the wine business from the outside, this is not really a story about one bottle edging out another. It is a...

Continue Reading
Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 113

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Ajman Media Forum Puts Trust Ahead of AI Speed in 2026

Updated Category News Views 156

Algorithms may manufacture a flood of words, but they cannot inherit accountability. That was the sensible nerve running through Ajman Media Forum 2026, “The Signal,” inaugurated on November 19 by His Highness Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of the Executive Council. For all the fanfare that usually surrounds artificial...

Continue Reading
Rafay's Third Fast 500 Nod Tracks AI Cloud Buildout

Updated Category News Views 24

GPU warehouses are easy to admire and brutally hard to operate like a real business. Rafay Systems landing on Deloitte's 2026 Technology Fast 500 for a third straight year is another signal that the AI infrastructure scramble has moved well beyond simply finding chips. Somebody has to turn all that expensive compute into services customers can provision, use, measure and...

Continue Reading
Innogen's Arcera Deal Tests Its GLP-1 Global Reach

Updated Category News Views 115

A License Deal With Actual Cash Attached Drug licensing announcements can smell like expensive perfume: plenty of promise, hard to tell what is really in the bottle. This one at least arrives with a concrete number. Innogen Pharmaceuticals will receive US$38 million in upfront and near-term milestone payments from Arcera Life Sciences for Efsubaglutide Alfa, including a...

Continue Reading
FLX Opens a New Door to Pre-IPO Deal Flow for Advisors

Updated Category News Views 82

Private-market chatter has been leaking past the velvet rope for years, and advisors are sick of learning about it after a client already has a pitch deck in hand. FLX Networks is responding to that irritation by letting its eligible advisor and wealth-management members review select pre-IPO opportunities shared by other members. Announced November 19, 2026, the move is...

Continue Reading
Getac's Linux Certification Matters at the Rugged Edge

Updated Category News Views 73

Field computers rarely get applause, but they can decide whether a critical operation runs cleanly or turns into a very expensive mess. Getac’s November 19 announcement that its UX10, G140, and V120 rugged devices are certified for Red Hat Enterprise Linux is not the sort of headline that sends investors pounding the table. It is, however, the kind of plumbing work that...

Continue Reading

Top 5 Most Recently Viewed Articles

Globeleq Strengthens Leadership with Alasdair Martin's Appointment

Updated Category News Views 169

Globeleq Welcomes Alasdair Martin as Director of Private Customer Solutions Globeleq, a prominent independent power company in Africa, has appointed Alasdair Martin to the crucial role of Director of Private Customer Solutions. This appointment is a strategic move that aligns with the company's vision for growth through innovation and sustainable energy transformation in...

Continue Reading
Orthofix Medical's Q4 2026 Earnings: Unpacking The Numbers

Updated Category News Views 186

Earnings Breakdown Let's get into the nitty-gritty of Orthofix Medical's earnings for Q4 of 2026. Rollercoaster ride, anyone? They posted an earnings-per-share (EPS) of $0.24, which is a solid beat over the $0.12 consensus estimate. That's a clean 100% overcall—on paper, that's the kind of news that gets you smiling on your way to the bank. Honestly, an earnings double...

Continue Reading
bioAffinity Technologies Achieves Milestone with CyPath® Lung Test

Updated Category News Views 106

bioAffinity Technologies Celebrates Initial Success of CyPath® Lung b>bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), dedicated to advancing noninvasive cancer detection and lung disease diagnostics, has unveiled remarkable outcomes from its recent pilot marketing program for the CyPath® Lung test. Focused on enhancing patient care, the Texas beta launch has seen...

Continue Reading
Hamilton Beach Brands Reports Strong Q3 Performance for 2024

Updated Category News Views 145

Company Overview Hamilton Beach Brands Holding Company (NYSE: HBB) is an established leader in the design, marketing, and distribution of a variety of small electric household appliances and specialty products. With a portfolio that includes well-known consumer brands such as Hamilton Beach® and Proctor Silex®, the company continues its mission to enhance daily living...

Continue Reading
Melexis Expands Treasury Share Holdings with Recent Buyback

Updated Category News Views 155

Melexis Share Buy-Back Program Update Melexis is excited to share an update regarding its ongoing share buy-back program, originally announced several months ago. This initiative aims to enhance shareholder value and stabilize stock prices in today’s dynamic market environment. As part of this program, Melexis has recently engaged in notable share purchases on Euronext...

Continue Reading